Australians living with the debilitating disease cystic fibrosis will soon have access to a new treatment on the Pharmaceutical Benefits Scheme .
From April 1, new drug Trikafta will be available for the first time for Australians aged 12 years and older with cystic fibrosis. "Without PBS subsidy, around 1900 Australians would pay more than $250,000 a year for access to Trikafta," Health Minister Greg Hunt said.Australians living with the debilitating disease cystic fibrosis will soon have access to a new treatment on the Pharmaceutical Benefits Scheme .
"This treatment is out of reach for most Australians, and now that it will be available on the PBS, patients will only pay a maximum of $42.50 per script, or as little as $6.80 with a concession card."The average life expectancy for Australians with cystic fibrosis is just 47 years — significantly lower than average.One in 2500 Australian babies are born with cystic fibrosis and there is currently no cure.
look at my boobs😘 Jessica71559929
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Life-changing cystic fibrosis drug added to PBSAustralians with the debilitating disease cystic fibrosis will have access to a new treatment on the Pharmaceutical Benefits Scheme which previously cost $250,000.
Source: 9NewsAUS - 🏆 10. / 72 Read more »
Life-changing cystic fibrosis drug added to PBSAustralians with the debilitating disease cystic fibrosis will have access to a new treatment on the Pharmaceutical Benefits Scheme which previously cost $250,000.
Source: 9NewsAUS - 🏆 10. / 72 Read more »
Source: 7NewsMelbourne - 🏆 18. / 59 Read more »